Texas Yale Capital Corp. Gsk PLC Transaction History

Texas Yale Capital Corp.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $9,671 - $10,987	230 Added 3.98%	6,010 $262,000
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $18,908 - $22,437	470 Added 8.85%	5,780 $252,000
Q4 2021 Feb 10, 2022	BUY	$38.88 - $45.31 $2,721 - $3,171	70 Added 1.34%	5,310 $234,000
Q3 2021 Nov 08, 2021	BUY	$38.79 - $43.16 $203,259 - $226,158	5,240 New	5,240 $200,000
Q4 2017 Feb 07, 2018	SELL	$35.34 - $41.9 $326,788 - $387,449	-9,247 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $364,701 - $384,212	9,247	9,247 $375,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

Stay updated on Texas Yale Capital Corp. with notifications on news.